Interpharm Holdings Inc. (IPAH)
Россия
  • Россия
  • Украина

Interpharm Holdings Inc. (IPAH)

Contact Details

75 Adams Ave, Hauppauge, New York, USA 11788-3605
(631) 231-6021
75 Adams Ave, Hauppauge, New York, USA 11788-3605

General Information

Interpharm is in the business of developing, manufacturing, and distributing generic drugs in the United States. Interpharm currently markets products representing various dosage strengths for distinct drugs that it manufactures. Interpharm markets its products primarily to wholesalers and drug distributors principally through its internal sales staff as well as independent sales representatives.

Contact Information

Phone(631) 231-6021
Fax(631) 952-9587
Website 1http://www.amneal.com
Thomson Reuters PermID4295912568

Government Contracts

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Drugs Affecting Neoplasms And Endrocrine Systems

Company Size

Sales Volume$87.2 million

Ownership

Ticker SymbolIPAH
ExchangeOTC Bulletin Board Pink Sheets (PK)
Year Founded1992

Stocks

52-Week Range0 - 0
Average Volume (1M)122
Beta-6.78x
Market Cap.$0 Million
Last Dividend Amount0

Financials

Period EndingDec. 31, 2007Sep. 30, 2007Jun. 30, 2007Mar. 31, 2007
Total Revenue16,21417,70015,37019,910
Cost of Revenue13,94016,63013,10013,530
Gross Profit2,2741,0702,2706,380
Research Development2,9003,4505,9704,710
Selling General and Administrative3,3003,7703,7203,910
Depreciation and Amortization----
Other Operating Expenses----
Total Operating Expenses20,14023,85022,79022,150
Other Income/Expenses Net----
Earnings Before Interest and Taxes(3,926)(6,150)(7,420)(2,240)
Interest Expense980740470280
Income Before Tax(4,920)(6,890)(7,850)(2,590)
Income Tax Expense5,970-1,850(740)
Minority Interest----
Net Income from Continuing Ops(10,897)(6,900)(9,710)(1,852)
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items----
Net Income(10,897)(6,900)(9,710)(1,852)
Preferred Stock and Other Adjustments----
Net Income Applicable to Common Shares(10,897)(6,900)(9,710)(1,852)